Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UNITED THERAPEUTICS Corp Director's Dealing 2012

Mar 5, 2012

30320_dirs_2012-03-05_b0a5091c-a1ae-460a-b8bc-c073f8221241.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2012-03-02

Reporting Person: JEFFS ROGER (Director, President & COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-03-02 Common Stock M 3574 $27.97 Acquired 18863 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-03-02 Stock Options $27.97 M 3574 Disposed 2017-03-15 Common Stock (3574) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6773 Indirect

Footnotes

F1: Shares held by a family limited liability company of which the reporting person and his spouse are managing members.